| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.0M | +52.8% |
| Cost of Revenue | $6.5M | +58.4% |
| Gross Profit | $4.5M | +45.3% |
| R&D Expense | $194K | +201.1% |
| SG&A Expense | $9.6M | -14.5% |
| Operating Income | -$17.4M | +29.6% |
| Net Income | -$14.9M | +39.7% |
| EPS (Basic) | -$14.15 | +72.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $10.7M | +160.3% |
| Short-term Investments | $5.0M | +0.0% |
| Accounts Receivable | $1.9M | +36.3% |
| Inventory | $3.1M | +748.4% |
| Current Assets | $21.6M | +79.3% |
| Total Assets | $21.7M | -7.6% |
| Current Liabilities | $4.0M | +246.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.4M | +30.0% |
| Capital Expenditures | $6K | -92.5% |
| Investing Cash Flow | $5.0M | +116.1% |
| Financing Cash Flow | $14.3M | -61.7% |
| Free Cash Flow | -$7.5M | +30.5% |
| Total Liabilities |
| $8.5M |
| +632.5% |
| Stockholders' Equity | $7.9M | -64.5% |